source
- Takeda’s oral psoriasis drug outperforms Bristol Myers’ Sotyktu in Phase 3 trialTakeda announced that its experimental oral medication for plaque psoriasis achieved superior results compared with Bristol Myers Squibb’s Sotyktu in a head-to-head Phase 3 study. The trial measur…
- Genentech shuts infectious disease research unit and lays off senior scientists in latest R&D cutsGenentech announced another round of layoffs affecting its early research and development group. The cuts included the closure of its infectious disease research unit and the departure of several…